BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1030 related articles for article (PubMed ID: 24099962)

  • 1. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
    Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
    Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner.
    Han Q; Zhang C; Zhang J; Tian Z
    Hepatology; 2011 Oct; 54(4):1179-89. PubMed ID: 21721030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice.
    Ebert G; Poeck H; Lucifora J; Baschuk N; Esser K; Esposito I; Hartmann G; Protzer U
    Gastroenterology; 2011 Aug; 141(2):696-706, 706.e1-3. PubMed ID: 21684282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5'-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice.
    Han Q; Hou Z; Yin C; Zhang C; Zhang J
    Antiviral Res; 2019 Jan; 161():36-45. PubMed ID: 30448255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
    Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
    Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
    Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostimulatory siRNA with a uridine bulge leads to potent inhibition of HBV and activation of innate immunity.
    Lan T; Wei Z; He Y; Wan S; Liu L; Cheng B; Li R; Chen H; Liu G; Meng Z
    Virol J; 2021 Feb; 18(1):37. PubMed ID: 33602251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5'-triphosphate-siRNA against survivin gene induces interferon production and inhibits proliferation of lung cancer cells in vitro.
    Wang K; Chen X; Yan F; Xing Y; Yang X; Tu J; Chen Z
    J Immunother; 2013 Jun; 36(5):294-304. PubMed ID: 23719240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma differentiation-associated gene 5 senses hepatitis B virus and activates innate immune signaling to suppress virus replication.
    Lu HL; Liao F
    J Immunol; 2013 Sep; 191(6):3264-76. PubMed ID: 23926323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
    Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
    Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of hepatitis B virus replication and expression by RNA interference in vitro].
    Zhu C; Fan XG; Li N; Ying RS; Tian XF
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2503-6. PubMed ID: 16321280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus is inhibited by RNA interference in cell culture and in mice.
    Ying RS; Zhu C; Fan XG; Li N; Tian XF; Liu HB; Zhang BX
    Antiviral Res; 2007 Jan; 73(1):24-30. PubMed ID: 16844238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNA combinations mediate greater suppression of hepatitis B virus replication in mice.
    Li G; Fu L; Jiang J; Ping Y; Huang Y; Wang Y
    Cell Biochem Biophys; 2014 Jul; 69(3):641-7. PubMed ID: 24549857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
    Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
    Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effects of duplex RNA harboring 5'-terminal triphosphate on gene silencing and RIG-I mediated innate immune response.
    Baek SE; Kim H; Kim KB; Yoon S; Choe J; Suh W; Jeong YJ; Cho YH; Kim DE
    Biochem Biophys Res Commun; 2015 Jan; 456(2):591-7. PubMed ID: 25490387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
    Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells.
    Guo H; Jiang D; Ma D; Chang J; Dougherty AM; Cuconati A; Block TM; Guo JT
    J Virol; 2009 Jan; 83(2):847-58. PubMed ID: 18971270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatitis B virus expression and replication by RNA interference in HepG2.2.15.
    Zhao ZF; Yang H; Han DW; Zhao LF; Zhang GY; Zhang Y; Liu MS
    World J Gastroenterol; 2006 Oct; 12(37):6046-9. PubMed ID: 17009407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIG-I enhances interferon-α response by promoting antiviral protein expression in patients with chronic hepatitis B.
    Wu S; Lin J; Fu Y; Ou Q
    Antivir Ther; 2018; 23(7):575-583. PubMed ID: 29790851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.